Member of the Supervisory BoardDr. Claus T. Braestrup, M.D., was Member of the Supervisory Board of Evotec AG since June 12, 2013. He is Member of the Audit Committee at the Company. During his career, he gained experience from publicly traded international pharmaceutical companies as well as scientific and drug discovery qualifications. From 2003 to 2008, he served as President and CEO at H. Lundbeck AS, where he was head of research and development from 1998 to 2003. Previously, he served as head of preclinical drug research at Schering AG from 1994 to 1998, at Novo Nordisk AS as president of the Diabetes Care Division, President of its CNS Division and Vice President of pharmaceutical research and at Ferrosan AS as scientist in drug discovery from 1978 to 1984. He serves as Chairman of the Board of Saniona AB and as Member of the Board of Bavarian Nordic AS, Kastan ApS and Evolva SA. He holds a Masters degree in Chemical Engineering and is MS in Biochemistry. He is Doctor of Medical Science and former Adjunct Professor in Neuroscience at the University of Copenhagen.
Age: 71 Executive Since 2013